$JNJ

2 theses

bullish 0%neutral 0%bearish 100%

Avg return (1w)

-1.4%

Win rate (1w)

50% (2 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 2, 4:30 PM ET

$JNJSEC Form 4bearish

Schmid Timothy · EVP, WW Chair, MedTech at JOHNSON & JOHNSON · 29d agono track record yet

Sold 33,597 @ $274.74 avg · $9,230,440 · 2026-09-02

Form 4: Schmid Timothy sold JNJ

Schmid Timothy (EVP, WW Chair, MedTech at JOHNSON & JOHNSON) reported an open-market sale of 33,597 shares of JNJ at an average $274.74, roughly $9,230,440, in a Form 4 filed 2026-09-04.

At post $275.23Now $256.03-7.0% since postedas of Oct 2, 4:30 PM ET

1d—

3d—

1w-3.5%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$JNJSEC Form 4bearish

Taubert Jennifer L · EVP, WWC. Innovative Medicine at JOHNSON & JOHNSON · 45d agono track record yet

Sold 15,000 @ $263.36 avg · $3,950,400 · 2026-08-17

Form 4: Taubert Jennifer L sold JNJ

Taubert Jennifer L (EVP, WWC. Innovative Medicine at JOHNSON & JOHNSON) reported an open-market sale of 15,000 shares of JNJ at an average $263.36, roughly $3,950,400, in a Form 4 filed 2026-08-18.

At post $271.11Now $256.03-5.6% since postedas of Oct 2, 4:30 PM ET

1d+0.8%

3d-0.3%

1w+0.7%

1m-0.3%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.